Anti-TCR Antibody (NKTT320) represents a highly specialized humanized agonistic monoclonal antibody specifically engineered to target the invariant T-cell receptor of iNKT cells with exceptional binding affinity and selectivity, effectively facilitating the measurable activation and expansion of this unique lymphocyte subset across various preclinical experimental models to evaluate the induction of immunomodulatory cytokines during strictly monitored laboratory observation periods.